The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFocusrite Regulatory News (TUNE)

Share Price Information for Focusrite (TUNE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 380.00
Bid: 370.00
Ask: 390.00
Change: 0.00 (0.00%)
Spread: 20.00 (5.405%)
Open: 380.00
High: 380.00
Low: 380.00
Prev. Close: 380.00
TUNE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Dividend Timetable Correction

26 Apr 2023 14:39

RNS Number : 5809X
Focusrite PLC
26 April 2023
 

Focusrite plc ("Focusrite" or the "Group")

Interim Dividend Timetable Correction 

The final dividend details stated in Focusrite's Half Year Results announcement, released at 7.00am on 25 April 2023 under RNS No 2959X, stated an incorrect Ex-Dividend Date.

The correct Ex-Dividend Date and Record Date for the interim dividend in respect of the 6 months to 28 February 2023 of 2.1 pence per share is 11 May 2023 and 12 May 2023, respectively. The dividend will be payable on 9 June 2023.

 All other details remain unchanged.

Enquiries:

 

Focusrite plc:

Tim Carroll (CEO)

+44 1494 462246

Sally McKone (CFO)

+44 1494 462246

Investec Bank plc (Nominated Adviser and Joint Broker)

David Flin

Ed Knight

William Brinkley

Peel Hunt LLP (Joint broker)

Paul Gillam

Michael Burke

James Smith

+44 20 7597 5970

 

 

 

 

+44 20 7418 8900

Belvedere Communications

  +44 20 3008 6864

John West

Llew Angus

Notes to Editors

Focusrite plc is a global audio products group that develops and markets proprietary hardware and software products. Used by audio professionals and musicians, its solutions facilitate the high-quality production of recorded and live sound. The Group trades under eleven established brands: Focusrite, Focusrite Pro, Novation, Ampify, ADAM Audio, Martin Audio, Optimal Audio, Linea Research, Sequential, Oberheim and Sonnox.

With a high-quality reputation and a rich heritage spanning decades, its brands are category leaders in the music-making and audio recording industries. Focusrite and Focusrite Pro design and manufacture audio interfaces and other products for recording musicians, producers and professional audio facilities. Novation and Ampify products are used in the creation of electronic music, from synthesisers and grooveboxes to industry-shaping controllers and inspirational music-making apps. ADAM Audio studio monitors have earned a worldwide reputation based on technological innovation in the field of studio loudspeaker technology. Martin Audio designs and manufactures performance-ready systems across the spectrum of sound reinforcement applications. Linea Research designs, develops, manufactures and sells market innovative professional audio equipment globally. Sequential designs and manufactures high-end analogue synthesizers under the Sequential and Oberheim brands. Sonnox is a leading designer of innovative, high quality, award-winning audio processing software plug-ins for professional audio engineers.

The Group has offices in four continents and a global customer base with a distribution network covering approximately 240 territories.

Focusrite plc is traded on the AIM market of the London Stock Exchange.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FURUNOOROVUSUAR
Date   Source Headline
13th Sep 20177:00 amRNSTrading Update
31st Aug 20177:00 amRNSTR-1: Notification of major holdings
19th May 20173:40 pmRNSHolding(s) in Company
3rd May 20177:00 amRNSHalf Year Results for the period ended 28 Feb 2017
20th Mar 20177:00 amRNSTrading Update
24th Feb 20173:56 pmRNSPDMR Grant of Share Options
10th Jan 20172:46 pmRNSResult of AGM
10th Jan 20177:00 amRNSAGM Statement
7th Dec 20164:28 pmRNSTR-1: Notification of Major Interest in Shares
6th Dec 201611:00 amRNSAnalyst and Investor Day
5th Dec 20163:13 pmRNSDirector/PDMR Shareholding
5th Dec 20167:00 amRNSAppointment of Chief Executive Officer
24th Nov 20165:09 pmRNSDirector/PDMR Shareholding
22nd Nov 20166:15 pmRNSDirector/PDMR Shareholding
22nd Nov 20167:00 amRNSFinal Results for the Year Ended 31 August 2016
6th Oct 20167:00 amRNSFurther Expansion into Asia
14th Sep 20167:00 amRNSPre-close Trading Update
19th Jul 20167:00 amRNSBoard Change
2nd Jun 20167:00 amRNSMajor New Product Upgrade and Launch
6th May 20162:56 pmRNSHolding(s) in Company & Total Voting Rights
26th Apr 20167:00 amRNSHalf Year Results
19th Apr 20169:22 amRNSNotice of Interim Results
14th Mar 20167:00 amRNSTrading Update
29th Jan 20163:34 pmRNSResult of AGM
29th Jan 20167:00 amRNSAGM Statement and Update on Trading
9th Dec 20157:00 amRNSResults for the year ended 31 August 2015
23rd Nov 20157:00 amRNSNotice of Preliminary Results
15th Sep 20157:00 amRNSPre-close Trading Update
6th May 20157:01 amRNSDividend Timetable
29th Apr 20157:00 amRNSHalf Year Results for the period ended 28 Feb 2015
18th Mar 20157:00 amRNSQ1 products and news update
12th Mar 20157:00 amRNSTrading Update
12th Dec 20145:37 pmRNSTR-1: Notification of Major Interest in Shares
11th Dec 20147:00 amRNSAdmission to AIM and first day of dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.